Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims. However, some of these unproven therapies may have underlying genetic reasons for not being effective and resulting in fatal adverse effects as found with hydroxychloroquine.
Recently published a study in Nature Genomic Medicine.
Release date: 26 August 2020
Source: University of Minnesota